E815
TEAS SECTION 8 & 15 RECEIVED
13/07/2026
Voltar para busca
Dado oficial do USPTO
DERMAGNOSTIX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
DERMAGNOSTIX
ST13
US500000088442928Classe
1, 5, 42
Pedido
88442928
Registro
6098893
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
13/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
23/05/2019
Data de registro
14/07/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/07/2020
Última transação
13/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Freiburg, DE
Examinador
BEDNARZ, DUSTIN THOMAS
Unidade examinadora
N30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
DERMAGNOSTIX R&D GMBH
Helmholtz Zentrum Muenchen - Deutsches Forschungszentrum fuer Gesundheit und Umwelt
Representantes
Frank S. Benjamin Dentons US LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Biochemicals for use in industry and scienceIn particular oligonucleotides and antibodies for qualitatively and quantitatively determining the expression of biomarkers for detecting skin diseasesin particular for detecting psoriasis and atopic eczema and for distinguishing between psoriasis and atopic eczemaall for scientific and research use; Diagnostic kits for commercial and scientific purposes for detecting skin diseasespredominantly consisting of biochemical reagentsin particular containing oligonucleotides and antibodies for qualitatively and quantitatively determining the expression of biomarkers for detecting skin diseasesin particular for detecting psoriasis and atopic eczema and for distinguishing between psoriasis and atopic eczemaall for scientific and research use; Diagnostic agents other than for medical and veterinary purposes
Classe 5
PharmaceuticalsIn particular products for treating skin diseasesin particular for treating psoriasis and atopic eczema; Diagnostic preparations for medical purposesin particular in the field of dermatologyin particular in the field of diagnosing skin diseasesin particular for diagnosing dermato-oncological diseases and for diagnosing inflammatory skin diseasesin particular for diagnosing psoriasis and atopic eczema and for distinguishing between psoriasis and atopic eczemain particular containing oligonucleotides and antibodies
Classe 42
Scientific and industrial research in particular in the biochemicaldiagnostic and pharmaceutical fields; Laboratory research services relating to pharmaceuticalsin particular in the field of dermatologyin particular in the field of diagnosing skin diseasesin particular for diagnosing dermato-oncological diseases and for diagnosing inflammatory skin diseasesin particular for diagnosing psoriasis and atopic eczema and for distinguishing between psoriasis and atopic eczemaall for scientific and industrial research purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
14/07/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
25/07/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
25/07/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
25/07/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/11/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/11/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/11/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/11/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/11/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/11/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
14/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/04/2020
PUBO
PUBLISHED FOR OPPOSITION
28/04/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/04/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
23/03/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
20/03/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/03/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
17/03/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
16/03/2020
GNSL
LETTER OF SUSPENSION E-MAILED
16/03/2020
CNSL
SUSPENSION LETTER WRITTEN
16/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/03/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/02/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
20/02/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20/02/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20/02/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
20/02/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/02/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
20/08/2019
GNRT
NON-FINAL ACTION E-MAILED
20/08/2019
CNRT
NON-FINAL ACTION WRITTEN
20/08/2019
DOCK
ASSIGNED TO EXAMINER
13/08/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/06/2019
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
07/06/2019
ALIE
ASSIGNED TO LIE
03/06/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
29/05/2019
NWAP
NEW APPLICATION ENTERED
27/05/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DERMAGNOSTIX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.